
23andMe Launches Its First Licensed Drug
23andMe has just introduced its first in-house drug licensed to a Spanish drug company named Almirall. The drug was designed to target inflammatory processes and autoimmune conditions. Read this brief report to learn more about the drug itself as well as 23andMe’s plans for the future in pharmacology.